Multicomponent Meningococcal Serogroup B Vaccine (4CMenB; Bexsero): A Review of its Use in Primary and Booster Vaccination.
- Published in:
- BioDrugs, 2013, v. 27, n. 3, p. 263, doi. 10.1007/s40259-013-0029-2
- By:
- Publication type:
- Article
Works matching IS 11738804 AND DT 2013 AND VI 27 AND IP 3
Results: 10
1
2
Regorafenib for Gastrointestinal Malignancies.
- Published in:
- BioDrugs, 2013, v. 27, n. 3, p. 213, doi. 10.1007/s40259-013-0014-9
- By:
- Publication type:
- Article
3
Gene Therapy for Fabry Disease: A Review of the Literature.
- Published in:
- BioDrugs, 2013, v. 27, n. 3, p. 237, doi. 10.1007/s40259-013-0032-7
- By:
- Publication type:
- Article
4
CD6 as a Therapeutic Target in Autoimmune Diseases: Successes and Challenges.
- Published in:
- BioDrugs, 2013, v. 27, n. 3, p. 191, doi. 10.1007/s40259-013-0027-4
- By:
- Publication type:
- Article
5
Dasatinib: A Guide to Its Use in Chronic Myeloid Leukemia in the EU.
- Published in:
- BioDrugs, 2013, v. 27, n. 3, p. 275, doi. 10.1007/s40259-013-0024-7
- By:
- Publication type:
- Article
6
Belimumab Therapy in Systemic Lupus Erythematosus.
- Published in:
- BioDrugs, 2013, v. 27, n. 3, p. 225, doi. 10.1007/s40259-013-0031-8
- By:
- Publication type:
- Article
7
The Outlook for Alemtuzumab in Multiple Sclerosis.
- Published in:
- BioDrugs, 2013, v. 27, n. 3, p. 181, doi. 10.1007/s40259-013-0028-3
- By:
- Publication type:
- Article
8
Adalimumab: A Review of Its Use in the Treatment of Patients with Ulcerative Colitis.
- Published in:
- BioDrugs, 2013, v. 27, n. 3, p. 247, doi. 10.1007/s40259-013-0033-6
- By:
- Publication type:
- Article
9
Stem Cell Therapy in Osteoarthritis: A Step Too Far?
- Published in:
- BioDrugs, 2013, v. 27, n. 3, p. 175, doi. 10.1007/s40259-013-0017-6
- By:
- Publication type:
- Article
10
Development and Regulation of Biosimilars: Current Status and Future Challenges.
- Published in:
- BioDrugs, 2013, v. 27, n. 3, p. 203, doi. 10.1007/s40259-013-0020-y
- By:
- Publication type:
- Article